Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E23.84 EPS (ttm)5.63 Insider Own0.10% Shs Outstand2.62B Perf Week8.94%
Market Cap351.03B Forward P/E14.12 EPS next Y9.50 Insider Trans-3.46% Shs Float2.62B Perf Month-5.52%
Income15.12B PEG4.30 EPS next Q2.08 Inst Own70.80% Short Float0.78% Perf Quarter-7.01%
Sales82.06B P/S4.28 EPS this Y0.50% Inst Trans0.02% Short Ratio1.91 Perf Half Y2.27%
Book/sh22.60 P/B5.94 EPS next Y9.93% ROA9.80% Target Price156.88 Perf Year-1.03%
Cash/sh7.37 P/C18.20 EPS next 5Y5.55% ROE25.50% 52W Range109.16 - 154.50 Perf YTD-8.02%
Dividend3.80 P/FCF35.10 EPS past 5Y-0.20% ROI17.30% 52W High-13.16% Beta0.65
Dividend %2.83% Quick Ratio1.00 Sales past 5Y2.00% Gross Margin66.60% 52W Low22.91% ATR7.40
Employees132200 Current Ratio1.30 Sales Q/Q1.70% Oper. Margin21.10% RSI (14)51.15 Volatility4.20% 5.88%
OptionableYes Debt/Eq0.47 EPS Q/Q34.40% Profit Margin18.40% Rel Volume0.93 Prev Close133.15
ShortableYes LT Debt/Eq0.45 EarningsApr 14 BMO Payout65.70% Avg Volume10.67M Price134.17
Recom2.00 SMA203.90% SMA50-4.29% SMA200-1.72% Volume9,971,580 Change0.77%
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Apr-05-20 10:23AM  These 19 companies are working on coronavirus treatments or vaccines heres where things stand MarketWatch
06:58AM  3 Coronavirus Stocks That Could Lead the Market to Recovery TipRanks
Apr-04-20 10:33AM  Ready to buy back into this market? If so, forget about Apple and grab these stocks instead, strategist says MarketWatch
Apr-03-20 07:35PM  The 5 Best Mutual Funds to Get Through the Coronavirus Crisis
05:36PM  How a fund manager is putting all his stable stocks through extreme stress-testing MarketWatch
05:24PM  3 S&P sectors climbed this week here are the stocks that rose and fell the most MarketWatch
04:20PM  Small Biotech Jumps On $100 Million Cancer Deal With Pharma Giant J&J Investor's Business Daily
11:16AM  Pharma Stock Roundup: JNJ & SNY's Coronavirus Product Development, Other Updates Zacks
10:57AM  Fate Therapeutics Surges on Immunotherapy Deal With J&J Zacks
10:51AM  Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In Zacks
08:00AM  Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? Investor's Business Daily
07:36AM  The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO Benzinga
06:00AM  Johnson & Johnson chief looks to the greater good Financial Times
05:00AM  Bull of the Day: Regeneron Pharmaceuticals, Inc. (REGN) Zacks
Apr-02-20 04:19PM  Recovering From the Coma
02:30PM  Yield-thirsty investors eye stock dividends as virus fears shrink bond payouts Reuters
09:00AM  This Robotic Surgery Behemoth Hit A Speed Bump Is ISRG Stock A Buy? Investor's Business Daily
08:00AM  Thousands of U.S. Factories Can Be Retooled to Fight Coronavirus, According to a New Survey
07:54AM  Coronavirus Vaccine Race Intensifies: 3 Stocks in Focus Zacks
Apr-01-20 05:59PM  Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development Zacks
04:45PM  Johnson & Johnson Postpones 2020 Medical Devices Business Review Due to the Coronavirus PR Newswire
12:10PM  Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again Zacks
09:42AM  Tiny Bay Area company aims to win coronavirus vaccine race with a tablet American City Business Journals
Mar-31-20 08:31PM  PRESS DIGEST- British Business - April 1 Reuters
05:55PM  Johnson & Johnson to Host Virtual Annual Meeting of Shareholders PR Newswire
05:45PM  Johnson & Johnson (JNJ) Stock Moves -1.48%: What You Should Know Zacks
04:48PM  These Are The Top 5 Dow Jones Stocks So Far In 2020 Investor's Business Daily
01:18PM  Hospitals allow in home testing, phone calls are considered telehealth Yahoo Finance Video
09:46AM  J&J Plans to Initiate Coronavirus Vaccine Study in September Zacks
08:12AM  Should iShares Morningstar Large-Cap Value ETF (JKF) Be on Your Investing Radar? Zacks
03:55AM  FirstFT: Todays top news Financial Times
12:46AM  PRESS DIGEST- Wall Street Journal - March 31 Reuters
Mar-30-20 06:47PM  US Indexes Close Higher Monday +8.00%
05:47PM  Stock investors are too optimistic theyre running up Abbott, Johnson & Johnson and General Motors without doing any research MarketWatch
05:43PM  Stay-at-Home Orders Expand; J&J in Vaccine Deal: Virus Update Bloomberg
05:30PM  The Dow Surged 691 Points Because Investors Have More Hope Covid-19 Will Be Beat
05:27PM  TREASURIES-Benchmark yield recovers in late trading Reuters
04:32PM  Dow Gains 691 Points As Coronavirus Lockdown Extends Through April 30 Investor's Business Daily
04:27PM  US STOCKS-Wall Street rallies, led by healthcare jump Reuters
04:27PM  Covid Report: Gilead Nears Coronavirus Data In 'Weeks'; J&J Bullish On Vaccine Investor's Business Daily
04:27PM  Dow books nearly 700-point gain as investors eye efforts to slow coronavirus spread MarketWatch
04:15PM  Johnson & Johnson Says Its Coronavirus Vaccine Could Be Ready Early Next Year
04:05PM  US Stock Market Overview – Stocks Rally, Led by Healthcare, Energy Bucks the Trend FX Empire
03:55PM  Johnson & Johnson, Merck share gains lead Dow's nearly 725-point surge MarketWatch
03:35PM  Wall Street Gains on Monday
02:54PM  Johnson & Johnson, Merck share gains contribute to Dow's nearly 575-point surge MarketWatch
02:05PM  US STOCKS-Wall St gains as U.S. extends shutdown to limit virus spread Reuters
02:05PM  Afternoon Market Stats in 5 Minutes Benzinga
01:58PM  Coronavirus update: 755,591 cases world-wide, 36,211 deaths; Italy, Spain and New York City struggle to cope MarketWatch
01:52PM  Dow soars 438 points on gains for Microsoft, Johnson & Johnson shares MarketWatch
01:02PM  When Will a Coronavirus Vaccine be Ready? These 9 Programs Are Making Progress.
12:52PM  Johnson & Johnson, Microsoft share gains lead Dow's 525-point surge MarketWatch
12:47PM  Johnson & Johnson, Merck share gains contribute to Dow's 490-point surge MarketWatch
12:39PM  US STOCKS- Wall St gains as U.S. extends shutdown to limit virus spread Reuters
12:22PM  Is Abbott A Buy After FDA Blesses Not One But Two Coronavirus Tests? Investor's Business Daily
12:07PM  Dow Jones Climbs 500 Points, As Stock Market Correction Continues; U.S. Coronavirus Cases Top 145,000 Investor's Business Daily
11:45AM  Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now Zacks
11:45AM  Johnson & Johnson, Intel share gains lead Dow's 425-point rally MarketWatch
11:30AM  Does Johnson & Johnson's Potential Coronavirus Vaccine Make It a Buy?
11:05AM  Johnson & Johnson Identifies Lead Coronavirus Vaccine Candidate
10:45AM  Dow's 325-point rally highlighted by gains in shares of Johnson & Johnson, Intel MarketWatch
10:29AM  US STOCKS-Wall St gains as investors weigh stimulus against shutdown Reuters
10:02AM  Johnson & Johnson Is Ready to Rally After Reaching a Downside Price Target
09:38AM  Dow Jones Today, Climb On Coronavirus News, Spending; Johnson & Johnson, Abbott Labs Jump Investor's Business Daily
09:37AM  Stocks - Abbott, J&J Rise in Premarket on Covid-19 Treatment Hopes
09:22AM  Johnson & Johnson identifies a lead COVID-19 vaccine candidate American City Business Journals
09:08AM  US STOCKS-Wall St set to open higher as investors weigh stimulus against shutdown Reuters
08:27AM  J&J to start human testing of coronavirus vaccine by September Reuters
07:41AM  Johnson & Johnson, U.S. government plan one billion doses of coronavirus vaccine Reuters
07:38AM  J&J has a COVID-19 vaccine candidate, Phase 1 trials to start in September MarketWatch
07:36AM  Johnson & Johnson says testing of coronavirus vaccine to begin by September Reuters
07:32AM  Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use PR Newswire
Mar-29-20 07:23PM  Johnson & Johnson Rebounds Below 'Reversion to the Mean' Investopedia
Mar-27-20 11:41AM  Contractors can expect more funding, and flexibility, from coronavirus stimulus package American City Business Journals
Mar-26-20 11:51AM  Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus +6.01%
Mar-25-20 07:10PM  Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus
07:04PM  The Top Health Care Companies in the World Investopedia
06:57PM  J&J's Chief Scientific Officer predicts vaccinations against coronavirus within 12 months Yahoo Finance
05:56PM  'We are making good progress with a vaccine' says JNJ Chief Scientific Officer on coronavirus Yahoo Finance Video
05:45PM  Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
05:21PM  8 Dividend Consumer Stocks to Buy for Income amp; Growth Kiplinger
04:22PM  Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus
11:13AM  EU says Johnson & Johnson's deal for Takeda patch may harm competition Reuters
11:00AM  EU regulators to probe Johnson & Johnson's Takeda deal Reuters
09:38AM  Johnson & Johnson Weathers Storm but Needs to Build a New Base
Mar-23-20 05:51PM  US Indexes Close Lower Monday -7.30%
03:52PM  Dow's 486-point drop led by losses in Chevron, United Technologies stocks MarketWatch
02:51PM  Dow's 550-point fall led by losses in United Technologies, Chevron shares MarketWatch
01:51PM  United Technologies, Chevron share losses contribute to Dow's 311-point fall MarketWatch
01:31PM  Glaxo's Long-Acting HIV Regimen Cabenuva Gets Canada's Nod Zacks
12:56PM  52-Week Company Lows
08:44AM  Intra-Cellular prices schizophrenia drug at $1,320 per month Reuters
Mar-21-20 06:50PM  Stocks That Fell to 3-Year Lows in the Week of March 20
Mar-20-20 02:17PM  How to Invest in a Time of Turmoil -5.64%
10:52AM  Pharma Stock Roundup: SNY, RHHBY, PFE's Coronavirus Product Development & Other Updates Zacks
09:40AM  Does ibuprofen make the coronavirus worse? Is it still safe to take aspirin? MarketWatch
07:15AM  Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? Simply Wall St.
Mar-19-20 07:18PM  U.S. FDA says no scientific evidence that ibuprofen worsens coronavirus Reuters -5.86%
02:39PM  My Top 10 Stock Watch List Zacks
10:47AM  Dow drops 186 points on losses for Coca-Cola, United Technologies stocks MarketWatch
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Option Exercise90.4419,2241,738,61975,039Feb 25 04:23 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Sale147.9639,2245,803,58335,815Feb 25 04:23 PM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM